Recalibrating the use of race in medical research

JAMA - Journal of the American Medical Association

Volumn 325, Issue 7, 2021, Pages 623-624

  Ioannidis, John P A ^a   Powe, Neil R ^b   Yancy, Clyde ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; ANCESTRY GROUP; ATTITUDE TO HEALTH; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; CORONAVIRUS DISEASE 2019; DEMOGRAPHY; DIAGNOSTIC ACCURACY; ETHNIC GROUP; EUROPEAN; FINANCIAL MANAGEMENT; GENETIC CODE; HEALTH BEHAVIOR; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE MANAGEMENT; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH DISPARITY; HEALTH EQUITY; HEALTH INSURANCE; HEART FAILURE; HISPANIC; HUMAN; HYPERTENSION; KIDNEY FUNCTION; LEPROSY; LUNG FUNCTION; MEDICAL PRACTICE; MEDICAL RESEARCH; MEDICAL SOCIETY; NOTE; PATIENT REGISTRY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; RACISM; SCIENTIST; SOCIAL ASPECT; SOCIAL DETERMINANTS OF HEALTH; SOCIAL INTERACTION; SOCIAL ISOLATION; SOCIAL PROBLEM; SOCIAL STATUS; SOCIOLOGY; THERAPY EFFECT; TREATMENT OUTCOME; UNITED STATES; WHOLE GENOME SEQUENCING; GENETICS; SOCIOECONOMICS;

BIOMEDICAL RESEARCH; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; HUMANS; RACISM; SOCIAL DETERMINANTS OF HEALTH; SOCIOECONOMIC FACTORS;

EID: 85099824972     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2021.0003     Document Type: Note

References (10)

1. Lin SS, Kelsey JL. Use of race and ethnicity in epidemiologic research: concepts, methodological issues, and suggestions for research. Epidemiol Rev. 2000; 22 (2): 187-202. doi: 10.1093/oxfordjournals.epirev.a018032 11218371
2. Fullilove MT. Comment: abandoning "race" as a variable in public health research-an idea whose time has come. Am J Public Health. 1998; 88 (9): 1297-1298. doi: 10.2105/AJPH.88.9.1297 9736864
3. Bhopal R, Donaldson L. White, European, Western, Caucasian, or what? inappropriate labeling in research on race, ethnicity, and health. Am J Public Health. 1998; 88 (9): 1303-1307. doi: 10.2105/AJPH.88.9.1303 9736867
4. Liu P, Ross JS, Ioannidis JP, Dhruva SS, Vasiliou V, Wallach JD. Prevalence and significance of race and ethnicity subgroup analyses in Cochrane intervention reviews. Clin Trials. 2020; 17 (2): 231-234. doi: 10.1177/1740774519887148 31709809
5. Mills MC, Rahal C. A scientometric review of genome-wide association studies. Commun Biol. 2019; 2: 9. doi: 10.1038/s42003-018-0261-x 30623105
6. Martin AR, Kanai M, Kamatani Y, Okada Y, Neale BM, Daly MJ. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. 2019; 51 (4): 584-591. doi: 10.1038/s41588-019-0379-x 30926966
7. Bloche MG. Race-based therapeutics. N Engl J Med. 2004; 351 (20): 2035-2037. doi: 10.1056/NEJMp048271 15533852
8. Taylor AL, Wright JT Jr. Should ethnicity serve as the basis for clinical trial design? importance of race/ethnicity in clinical trials: lessons from the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Circulation. 2005; 112 (23): 3654-3660. doi: 10.1161/CIRCULATIONAHA.105.540443 16330707
9. Ramamoorthy A, Pacanowski MA, Bull J, Zhang L. Racial/ethnic differences in drug disposition and response: review of recently approved drugs. Clin Pharmacol Ther. 2015; 97 (3): 263-273. doi: 10.1002/cpt.61 25669658
10. Diao JA, Wu GJ, Taylor HA, Clinical implications of removing race from estimates of kidney function. JAMA. 2020; 325 (2): 184-186. doi: 10.1001/jama.2020.22124 33263721